Companies included in BIB Page 2
This is BIB's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 101–200 of 278.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| WVE | WaVe Life Sciences Ltd. | 7,723 | NS | 0.117306% |
| MLYS | Mineralys Therapeutics, Inc. | 3,654 | NS | 0.11658% |
| RARE | Ultragenyx Pharmaceutical, Inc. | 4,455 | NS | 0.113621% |
| DYN | Dyne Therapeutics, Inc. | 6,595 | NS | 0.112326% |
| MAZE | Maze Therapeutics, Inc. | 2,222 | NS | 0.110458% |
| STOK | Stoke Therapeutics, Inc. | 2,638 | NS | 0.104732% |
| GRAL | GRAIL, Inc. | 1,800 | NS | 0.104475% |
| KNSA | Kiniksa Pharmaceuticals International plc | 2,086 | NS | 0.101195% |
| HROW | Harrow, Inc. | 1,710 | NS | 0.101022% |
| OCUL | Ocular Therapeutix, Inc. | 9,837 | NS | 0.095892% |
| OLMA | Olema Pharmaceuticals, Inc. | 3,632 | NS | 0.095839% |
| SNDX | Syndax Pharmaceuticals, Inc. | 4,014 | NS | 0.095021% |
| RXRX | Recursion Pharmaceuticals, Inc. | 23,743 | NS | 0.095013% |
| AUPH | Aurinia Pharmaceuticals, Inc. | 6,088 | NS | 0.094065% |
| BCRX | BioCryst Pharmaceuticals, Inc. | 9,722 | NS | 0.092757% |
| PHVS | Pharvaris NV | 2,958 | NS | 0.091569% |
| VCEL | Vericel Corp. | 2,335 | NS | 0.090844% |
| RLAY | Relay Therapeutics, Inc. | 8,003 | NS | 0.089533% |
| TYRA | Tyra Biosciences, Inc. | 2,464 | NS | 0.089495% |
| ELVN | Enliven Therapeutics, Inc. | 2,741 | NS | 0.088736% |
| AGIO | Agios Pharmaceuticals, Inc. | 2,692 | NS | 0.088735% |
| SRPT | Sarepta Therapeutics, Inc. | 4,838 | NS | 0.088414% |
| ZYME | Zymeworks, Inc. | 3,456 | NS | 0.087766% |
| Genmab A/S | Genmab A/S | 2,699 | NS | 0.086641% |
| DFTX | Definium Therapeutics, Inc. | 4,548 | NS | 0.086536% |
| INVA | Innoviva, Inc. | 3,453 | NS | 0.086447% |
| ORKA | Oruka Therapeutics, Inc. | 2,236 | NS | 0.083896% |
| AMLX | Amylyx Pharmaceuticals, Inc. | 5,071 | NS | 0.083881% |
| ANIP | ANI Pharmaceuticals, Inc. | 1,037 | NS | 0.083561% |
| NVAX | Novavax, Inc. | 7,504 | NS | 0.082969% |
| HRMY | Harmony Biosciences Holdings, Inc. | 2,660 | NS | 0.082779% |
| SION | Sionna Therapeutics, Inc. | 2,061 | NS | 0.082116% |
| NRIX | Nurix Therapeutics, Inc. | 4,680 | NS | 0.081495% |
| RAPT Therapeutics, Inc. | RAPT Therapeutics, Inc. | 1,279 | NS | 0.08086% |
| LEGN | Legend Biotech Corp. | 3,888 | NS | 0.080549% |
| NTLA | Intellia Therapeutics, Inc. | 5,348 | NS | 0.080357% |
| ARDX | Ardelyx, Inc. | 11,220 | NS | 0.080134% |
| IOVA | Iovance Biotherapeutics, Inc. | 18,330 | NS | 0.077149% |
| NVCR | Novocure Ltd. | 5,171 | NS | 0.077077% |
| TRVI | Trevi Therapeutics, Inc. | 5,921 | NS | 0.076958% |
| ANAB | AnaptysBio, Inc. | 1,278 | NS | 0.076713% |
| TNGX | Tango Therapeutics, Inc. | 6,219 | NS | 0.075542% |
| MBX | MBX Biosciences, Inc. | 2,073 | NS | 0.073575% |
| EYPT | EyePoint, Inc. | 3,822 | NS | 0.073181% |
| KOD | Kodiak Sciences, Inc. | 2,450 | NS | 0.071595% |
| ZBIO | Zenas Biopharma, Inc. | 2,478 | NS | 0.071197% |
| IMCR | Immunocore Holdings plc | 2,015 | NS | 0.070968% |
| RAPP | Rapport Therapeutics, Inc. | 2,201 | NS | 0.069671% |
| CRVS | Corvus Pharmaceuticals, Inc. | 3,449 | NS | 0.068672% |
| PGEN | Precigen, Inc. | 16,338 | NS | 0.067518% |
| ATAI | AtaiBeckley, Inc. | 16,770 | NS | 0.066378% |
| COLL | Collegium Pharmaceutical, Inc. | 1,460 | NS | 0.066337% |
| ORIC | ORIC Pharmaceuticals, Inc. | 4,497 | NS | 0.065952% |
| SEPN | Septerna, Inc. | 2,067 | NS | 0.065406% |
| VIR | Vir Biotechnology, Inc. | 6,424 | NS | 0.063673% |
| Alvotech SA | Alvotech SA | 14,454 | NS | 0.062884% |
| TSHA | Taysha Gene Therapies, Inc. | 12,648 | NS | 0.062474% |
| SVRA | Savara, Inc. | 9,395 | NS | 0.06167% |
| GLUE | Monte Rosa Therapeutics, Inc. | 3,007 | NS | 0.058199% |
| SANA | Sana Biotechnology, Inc. | 12,300 | NS | 0.056464% |
| PAHC | Phibro Animal Health Corp. | 946 | NS | 0.05631% |
| Grifols SA | Grifols SA | 5,633 | NS | 0.055894% |
| Day One Biopharmaceuticals, Inc. | Day One Biopharmaceuticals, Inc. | 4,741 | NS | 0.054797% |
| ABCL | AbCellera Biologics, Inc. | 13,822 | NS | 0.054408% |
| INBX | Inhibrx Biosciences, Inc. | 672 | NS | 0.054318% |
| GERN | Geron Corp. | 29,476 | NS | 0.053996% |
| URGN | UroGen Pharma Ltd. | 2,162 | NS | 0.051156% |
| XERS | Xeris Biopharma Holdings, Inc. | 7,662 | NS | 0.05113% |
| MNKD | MannKind Corp. | 14,180 | NS | 0.050715% |
| Ventyx Biosciences, Inc. | Ventyx Biosciences, Inc. | 3,295 | NS | 0.050192% |
| FTRE | Fortrea Holdings, Inc. | 4,266 | NS | 0.049865% |
| QURE | uniQure NV | 2,877 | NS | 0.049032% |
| AVBP | ArriVent Biopharma, Inc. | 1,906 | NS | 0.047738% |
| PCRX | Pacira BioSciences, Inc. | 1,986 | NS | 0.047447% |
| AMPH | Amphastar Pharmaceuticals, Inc. | 2,122 | NS | 0.046808% |
| TBPH | Theravance Biopharma, Inc. | 2,340 | NS | 0.046565% |
| GHRS | GH Research plc | 2,864 | NS | 0.046375% |
| BCAX | Bicara Therapeutics, Inc. | 2,530 | NS | 0.046291% |
| SPRY | ARS Pharmaceuticals, Inc. | 4,564 | NS | 0.046182% |
| CGEM | Cullinan Therapeutics, Inc. | 2,728 | NS | 0.046106% |
| XNCR | Xencor, Inc. | 3,298 | NS | 0.045922% |
| CTMX | CytomX Therapeutics, Inc. | 7,823 | NS | 0.045807% |
| ABUS | Arbutus Biopharma Corp. | 8,881 | NS | 0.045126% |
| PHAT | Phathom Pharmaceuticals, Inc. | 3,285 | NS | 0.044989% |
| CSTL | Castle Biosciences, Inc. | 1,348 | NS | 0.043463% |
| OMER | Omeros Corp. | 3,274 | NS | 0.043018% |
| ARVN | Arvinas, Inc. | 2,965 | NS | 0.042902% |
| PRME | Prime Medicine, Inc. | 8,335 | NS | 0.041988% |
| KalVista Pharmaceuticals, Inc. | KalVista Pharmaceuticals, Inc. | 2,334 | NS | 0.041432% |
| JANX | Janux Therapeutics, Inc. | 2,777 | NS | 0.041211% |
| ANNX | Annexon, Inc. | 6,683 | NS | 0.040808% |
| PSNL | Personalis, Inc. | 4,101 | NS | 0.040514% |
| Esperion Therapeutics, Inc. | Esperion Therapeutics, Inc. | 11,038 | NS | 0.04032% |
| BIOA | BioAge Labs, Inc. | 1,656 | NS | 0.040213% |
| Mesoblast Ltd. | Mesoblast Ltd. | 2,264 | NS | 0.039128% |
| KURA | Kura Oncology, Inc. | 4,018 | NS | 0.038248% |
| ZLAB | Zai Lab Ltd. | 1,808 | NS | 0.037891% |
| CMPS | Compass Pathways plc | 4,351 | NS | 0.032736% |
| RIGL | Rigel Pharmaceuticals, Inc. | 838 | NS | 0.031744% |
| ALLO | Allogene Therapeutics, Inc. | 10,377 | NS | 0.031456% |
SEC N-PORT snapshot as of .